From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

“Immunotherapy and targeted therapy represent two of the biggest breakthroughs in cancer treatment in the last decade,” said co-corresponding author Ryan Corcoran, MD, ...

Dr. Manish Shah discusses the first ASCO guideline for advanced gastroesophageal cancer. He addresses biomarker testing to help guide therapy - including HER2 testing, mismatch repair testing, and ...

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 09 ...

Specifically, combination immunotherapy, in contrast to targeted therapy, produces more long-lasting tumor shrinkage, reduces the risk of disease progression in the central nervous system and ...

While immunotherapy is moving into multiple realms of oncology, it still has a strong influence in the treatment of lung cancer. The PD-1 inhibitors Opdivo (nivolumab) and Keytruda (pembrolizumab), ...

Patients with BRAF V600 mutation-positive metastatic melanoma who received an immune checkpoint inhibitor combination followed by targeted therapy survived longer than those who received the ...

Over the last 15 years, systemic therapy with immunotherapy and targeted therapies have significantly improved outcomes, explained Thomas Amatruda, MD, medical oncologist, Minnesota Oncology.

“Specifically, combination immunotherapy, in contrast to targeted therapy, produces more long-lasting tumor shrinkage, reduces the risk of disease progression in the central nervous system, and ...